HFE C282Y/H63D Compound Heterozygotes Are at Low Risk of Hemochromatosis-Related Morbidity

Gurrin, L.; Bertalli, N.; Dalton, G.; Osborne, N.; Constantine, C.; McLaren, C.; English, D.; Gertig, D.; Delatycki, M.; Nicoll, A.; Southey, M.; Hopper, J.; Giles, G.; Anderson, G.; Olynyk, John; Powell, L.; Allen, K.; Bahlo, M.; Vulpe, C.; Forrest, S.; Fletcher, A.

Access Status

Fulltext not available

Authors

Gurrin, L.

Bertalli, N.

Dalton, G.

Osborne, N.

Constantine, C.

McLaren, C.

English, D.

Gertig, D.

Delatycki, M.

Nicoll, A.

Southey, M.

Hopper, J.

Giles, G.

Anderson, G.

Olynyk, John

Powell, L.

Allen, K.

Bahlo, M.

Vulpe, C.

Forrest, S.

Fletcher, A.

Date

2009

Type

Journal Article

Metadata

Show full item record

Citation

Gurrin, L. and Bertalli, N. and Dalton, G. and Osborne, N. and Constantine, C. and McLaren, C. and English, D. et al. 2009. HFE C282Y/H63D Compound Heterozygotes Are at Low Risk of Hemochromatosis-Related Morbidity. Hepatology. 50 (1): pp. 94-101.

Source Title

Hepatology